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Results: IgG antibodies to human HSP60 were detected in 67% of the patients. HSP60 
antibodies were not associated with the risk of the development of MI or death (P>0.05). 
However, there were sex-based differences in the relation between the presence of 
HSP60 antibodies and the development of MI or death. In women, 130 of 204 (64%) had 
HSP60 antibodies. The risk of MI or death was increased in seroposltive compared to 
seronegative patients (relative hazards 2.2, 95% CI 1.10-4.47). This association per- 
sisted after adjustment for traditional risk factors, number of diseased vessels and clinical 
presentation. The adjusted relative hazard (with 95% CI) for MI or death was 2.1 (1.03- 
4.29). No association between HSP60 antibodies and infection or inflammation was 
found. In contrast, in men, 460 of 676 (68%) were HSP60 antibody seroposltive. There 
was no positive association between HSP60 seropositivity and MI or death (P>0.05). 
Conclusion: Although the mechanisms by which HSP60 antibodies predisposes to MI or 
death in CAD patients are unclear, this is the first study demonstrating a significant asso- 
ciation between human HSP60 antibodies and the risk of the development of MI or 
death. That this association occurs only in women is compatible with the conclusion that 
the mechanisms contributing to atherogenesis are different between men and women, 
and that in women, autoimmune mechanisms contribute to the development of athero- 
sclerosis, with one antigenic target being HSP60. 
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Background: Systemic activation of inflammation has been associated with poor prog- 
nosis in patients with chest pain. We prospectively studied the prognostic value of car- 
diac troponin T (cTnT) (marker of myocardial damage) and C-reactive protein (CRP), 
erythrocyte sedimentation rate (ESR) and white blood cell count (WBC) (markers of 
inflammation) in low to intermediate risk chest pain patients. 
Methods: Patients presenting at the cardiac emergency room with chest pain of -< 6 
hours duration and a normal or non-diagnostic electrocardiogram were eligible. Signifi- 
cant unstable coronary artery disease was ruled out using standard protocol and CK-MB 
and patients were subsequently discharged. CRP, ESR and WBC (admission) and serial 
cTnT (admission and 12 hours after symptom onset) were measured. CRP and cTnT 
results were blinded. All patients were followed up at 6 months. Cardiac events were car- 
diac death, acute myocardial infarction (AMI), and unstable angina (UA) requiring hospi- 
tal admission. 
Results: In 401 patients, cTnT and CRP results were available; 16 had a cardiac event: 
cardiac death (3), AMI (3) and UA (10). Results are displayed in the table. 
Cardiao event rate (%) Odds Ratio (95%CI) 
cTnT<0.06 ng/mL (Normal) 12/373 (3.2) 
cTnT_>O.06 ng/mL 4/28 (14.3) 5.01 (1.50-16.72) 0.019 
CRP<3.0 ng/mL (Normal) 4/247 (1.6) 
CRP>3.0 mg/L 12/154 (7.8) 5.13 (1.63-16.22) 0.003 
ESR<_ 13 mm/hr (Normal) 5/266 (1.9) 
ESR> 13 mm/hr 11/127 (8.7) 4.95 (1.68-14.57) 0.004 
Normal cTnT, Normal CRP 4/235 (1.7) 
Normal cTnT, Abnormal CRP 8/138 (5.8) 3.55 (1.05-12.03) 0.037 
Conclusion: In univariate analysis, serial cTnT, CRP, and ESR (but not WBC) each had 
significant prognostic value in low to intermediate risk chest pain patients in the emer- 
gency room. In patients with normal serial cTnT, CRP was able to distinguish low risk 
patients from not low-risk patients 
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BACKGROUND: The utility of troponin in risk stratification ofpatients that present o the 
emergency department(ED) with chest pain is well-established, but the prognostic signlt. 
icance of myoglobin(myo) in this patient population is less certain. We investigated 
whether the early measurement ofmyo contdbutad additional prognostic information i  a 
targe urban ED. 
METHODS: During 1999, 762 consecutive patients were evaluated in the ED for possi- 
ble myocardial infarction(MI). Patients with ST-segment elevation MI were excluded. 
Blood samples were collected at 0 hour, 90 minutes, and 9 hours for measurements of 
myo, CK-MB, and cardiac troponin I(cTnl) with a point-of-care device(Triage Cardiac, 
Biosite). 
RESULTS: At 30 days there were 121 patients with adverse events (AE)(43 deaths, 73 
MIs, and 46 revascularization procedures). Receiver operator curve analysis determined 
an optimum myo cut-point of 225 ng/ml to predict an AE. After multivariable adjustment 
for clinical factors, elevated serial myo values at presentation and 90 minutes were pre- 
dictive of an AE(table). Also, after adjusting for cTnl and CK-MB values at presentation 
and 90 minutes myo added additional prognostic information(odds ratio 4.03(2.15- 
7.54);p<O.000f)). 
ABSTRACTS- Myocardial Infarction and Ischemia 339A 
CONCLUSION: The early measurement of myo at presentation and 90 minutes adds 
additional prognostic information to clinical findings and CK-MB and cTnl values in ED 
patients with suspected MI. 
Odds Ratio of Elevated Myo for Adverse Event(gs% Confidence Interval) 
0 Hour 90 Minutes 9 Hours 
Multivariable Adjustment for 4.24(2.34-7.69) 10.68(4.32-26.43) 0.88 (0.37-2.08) 
Clinical Factors p<0.0001 p<0.0001 p=0.78 
